2026 data FDA MAUDE openFDA FDA Class III

Coronary Drug-Eluting Stent

Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.

OpenFDA device adverse-event casebook.

FDA MAUDE casebook

openFDA event book Coronary Drug-Eluting Stent HEAVY-BOOK · MAUDE

#33 of 1000 · 128,715 reports · 2003–2026

  • BOOK 128,715 reports
  • RANK #33 of 1000
  • DEATH 11,230 death-typed
  • INJ 62,169 injury-typed
  • MALF 55,031 malfunction
  • SPAN 2003–2026
  • PEAK 2012: 8,323
  • PHOTO Device

Nearest event-volume peer: Device, Hemostasis, Vascular (4,796 report gap)

Coronary Drug-Eluting Stent sits #33 of 1000 among tracked device types with 128,715 MAUDE reports spanning 2003–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →

Malfunction reports sit below the device-type norm

Coronary Drug-Eluting Stent carries 42.8% MALFUNCTION-coded reports, 22.1pp below the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.

  • DEATH 8.7% corpus 1.5% · above corpus mean (+7.2 pp)
  • INJ 48.3% corpus 30.3% · above corpus mean (+18.0 pp)
  • MALF 42.8% corpus 64.8% · below corpus mean (-22.1 pp)

Lead product-problem code Adverse Event Without Identified Device or Use Problem is 21% of coded problems · Lead manufacturer BOSTON SCIENTIFIC - GALWAY accounts for 21% of manufacturer-tagged reports · Top event location is 61% of location-tagged rows .

Coronary Drug-Eluting Stent in the event-volume neighbourhood

FDA MAUDE report totals among this device type and nearest nationwide peers

reports

What this shows Coronary Drug-Eluting Stent carries 128,715 MAUDE reports, ranked #33 of 1000.

Source FDA MAUDE via openFDA, aggregated by PlainHospital As of August 2026

Event Types

Injury 62,169 (48.3%)
Malfunction 55,031 (42.8%)
Death 11,230 (8.7%)
184 (0.1%)
Other 101 (0.1%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

55,699 (35.3%)
Required Intervention 32,097 (20.3%)
Hospitalization 20,064 (12.7%)
R 18,905 (12.0%)
Death 11,273 (7.1%)
Other 6,342 (4.0%)
L 5,016 (3.2%)
Life Threatening 2,588 (1.6%)
S 2,219 (1.4%)
H 1,612 (1.0%)
O 1,361 (0.9%)
Disability 472 (0.3%)
D 118 (0.1%)
Congenital Anomaly 19 (0.0%)

Top Product Problems

Adverse Event Without Identified Device or Use Problem 31,464
Failure to Advance 20,312
Occlusion Within Device 14,831
Material Deformation 13,739
Device remains implanted 12,199
Device Dislodged or Dislocated 10,930
Bent 9,086
Difficult to Remove 7,780
Unknown (for use when the device problem is not known) 5,837
Device Damaged Prior to Use 4,721
Break 3,973
Improper or Incorrect Procedure or Method 3,349
Detachment Of Device Component 2,423
Dislodged 2,192
Replace 2,155
Fracture 2,020
Device Damaged by Another Device 1,769
Difficult to Advance 1,728
Inflation Problem 1,638
Material Rupture 1,329

Yearly Trend

03
2003: 1,552
04
2004: 4,386
05
2005: 4,093
06
2006: 5,931
07
2007: 4,851
08
2008: 5,096
09
2009: 7,107
10
2010: 5,839
11
2011: 7,101
12
2012: 8,323
13
2013: 7,563
14
2014: 6,666
15
2015: 6,142
16
2016: 7,233
17
2017: 6,786
18
2018: 6,817
19
2019: 7,254
20
2020: 6,362
21
2021: 5,268
22
2022: 4,068
23
2023: 3,097
24
2024: 3,041
25
2025: 2,500
26
2026: 1,639

Reports in 2025 (2,500) held close to the prior two-year average of 3,069.

Related Entities for Coronary Drug-Eluting Stent

Event Locations

78,800 (61.2%)
I 41,310 (32.1%)
HOSPITAL 4,302 (3.3%)
OTHER 3,381 (2.6%)
UNKNOWN 331 (0.3%)
HOME 306 (0.2%)
NO INFORMATION 247 (0.2%)
INVALID DATA 16 (0.0%)
AMBULATORY SURGICAL FACILITY 13 (0.0%)
OUTPATIENT TREATMENT FACILITY 5 (0.0%)
OUTPATIENT DIAGNOSTIC FACILITY 2 (0.0%)
NURSING HOME 1 (0.0%)
PUBLIC VENUE 1 (0.0%)

Compare BOSTON SCIENTIFIC - GALWAY vs MEDTRONIC IRELAND →

Nationwide devices with a comparable volume-and-death footprint

Two openFDA-derived peer sets for Coronary Drug-Eluting Stent: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.

Similar report volume

Nearest other device types by FDA MAUDE report count (128,715 here).

Similar death-typed counts

Nearest other device types by death-typed report count (11,230 here), distinct from the volume row.

Disclaimer: MAUDE figures for Coronary Drug-Eluting Stent are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.

Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Coronary Drug-Eluting Stent; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.